CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and can afford the risks. Trading CFDs is high risk and is not suitable for everyone. Refer to our PDS and Target Market Determination. AFSL 513393
Open platformOpen platform

Arkema rises after Q3 earnings beat, FY guidance confirmation

By Reuters News

** Shares in Arkema AKE.PA are up 3.4%, on better-than-expected Q3 revenue, and 2026 outlook confirmation

** The French specialty chemicals maker reports sales for Q3 at €2.36 billion ($2.66 billion), ahead of the €2.27 bln consensus compiled by the company

** J.P.Morgan also notes a slight beat in Q3 adjusted EBITDA at €332 mln (+1% vs consensus), flagging results slightly better than the brokerage had forecast across all the key divisions in Specialty Materials

** The company maintains its 2026 outlook of a slightly higher year-on-year EBITDA at constant FX

** The broker says the guidance confirmation signals Arkema's ability to deliver a Q4 result better than normal seasonal patterns would imply, which "should be supportive for the shares"

** Including today's gains, the stock is up 14.7% year-to-date


($1 = 0.8880 euros)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.